PPT-MiSLE Investigational Product Training

Author : lois-ondreau | Published Date : 2018-11-03

Shipping Receipt and Infusion July 25 2018 Agenda Scheduling an infusion Colleen Cloud Receiving a shipment Tara Duke Inspecting the investigational product IP Tara

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "MiSLE Investigational Product Training" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

MiSLE Investigational Product Training: Transcript


Shipping Receipt and Infusion July 25 2018 Agenda Scheduling an infusion Colleen Cloud Receiving a shipment Tara Duke Inspecting the investigational product IP Tara Duke Preparing the IP for infusion Andrea Stress. Investigational Drug Service. Department of Pharmacy. Role of an IDS Pharmacy in Drug . S. tudies. Why . Investigational Product Processes Need To Be Strictly Governed. Describe Good Clinical Practice (GCP) guidelines as they pertain to study drugs. Adverse Drug Reactions (ADR). All . noxious . and unintended . responses to a medicinal product related to any . dose should . be . considered adverse . drug reactions. . Adverse Event (AE). Any untoward medical occurrence in a patient or clinical investigation . Outpatient Clinical Trials. Jessica Rinaldi, CCRP. Jessica.Rinaldi@jefferson.edu. Farber Institute for Neurosciences. Learning Objectives. At the end of this activity, learners should be able to:. Understand FDA Regulations and ICH GCP Guidelines for disposition of Investigational Product in Clinical Trials. Outpatient Clinical Trials. Jessica Rinaldi, CCRP. Farber Institute for Neurosciences. 21 CFR §312.62. “. Disposition of drug. . . An . investigator is required to maintain adequate records of the disposition of the drug, including . Introduction. Effects of AD Agitation. Agitation Treatment Options. Antipsychotics and AD. CATIE-AD. Discontinuing Antipsychotics. Provisional Definition of Agitation. Agitation Epidemiology. Case 1. : . The Chemistry, Manufacturing and Controls (CMC) Review. Dorota Matecka, Ph.D. . Office of Pharmaceutical Quality (OPQ), CDER. Outline. Pharmaceutical Quality. CMC Requirements for INDs . CMC Safety Concerns. 1 King & Spalding May 22, 2014 Presentation for Clinical and Translational Science Center ─ University of California, Davis Health System EAP Request Details - To be completed Requester Contact Information (Note “NA” for items not applicable.) Name of physician or regulatory agency requestor: 2. Name of institution (if applica Office of Research Protections, Policy, & Education. VHA Office of Research and Development. Department of Veterans Affairs . March 18, 2020. Dial in: 1 (213)-929-4232. Access Code: 152-743-880. Disclaimer. The content in this presentation was presented at HRS, May 2012. This presentation is for educational purposes only and should not be copied or presented without the permission of Boston Scientific Corp.. Radiation Emergencies Public Health Round Table: The Role of . Poison . Centers. National Center for Environmental Health. Division of Environmental Hazards and Health Effects. Disclosures. CDC, our planners, and our presenters wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. . When They Work – When They Don’t . And Why. Steven Walker. Co-Founder, Volunteer. Abigail Alliance for Better Access . to Developmental Drugs. Kakkis. . Everylife. Foundation Panel – March 27, 2014. VALIDATION TRAINING. LEVEL 2. Planning IMMERSION Level 1. "new version in line . with. the new guide. D1. D2. D3. D4. D5. BRAND THEORY. THE ESSENTIALS/CONTOURS/SERUMS. AGE DEFENSE THEORY/SENSITIVE SKINS, IMPERFECTIONS. Improving the health and . well-being of sufferers of chronic wounds. BRH Medical. Founded in 2010 by Mr. . Ilan. . Feferberg. , the company’s CTO, a graduate of the elite 8200 Israeli Intelligence Corp. .

Download Document

Here is the link to download the presentation.
"MiSLE Investigational Product Training"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents